Oberweis Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $243K | Sell |
|
|||||
|
2019
Q2 | $427K | Sell |
|
|||||
|
2019
Q1 | $5.61M | Buy |
|
|||||
|
2018
Q4 | $5.87M | Buy |
|
|||||
|
2018
Q3 | $9.77M | Sell |
|
|||||
|
2018
Q2 | $10.2M | Buy |
|
|||||
|
2018
Q1 | $8.06M | Sell |
|
|||||
|
2017
Q4 | $8.13M | Buy |
|
|||||
|
2017
Q3 | $7.01M | Buy |
|
|||||
|
2017
Q2 | $6M | Sell |
|
|||||
|
2017
Q1 | $5.39M | Sell |
|
|||||
|
2016
Q4 | $7.92M | Buy |
|
|||||
|
2016
Q3 | $7.57M | Sell |
|
|||||
|
2016
Q2 | $10.1M | Sell |
|
|||||
|
2016
Q1 | $9.83M | Sell |
|
|||||
|
2015
Q4 | $11M | Buy |
|
|||||
|
2015
Q3 | $8.17M | Buy |
|
|||||
|
2015
Q2 | $9.41M | Sell |
|
|||||
|
2015
Q1 | $9.67M | Sell |
|
|||||
|
2014
Q4 | $8.64M | Sell |
|
|||||
|
2014
Q3 | $7.91M | Sell |
|
|||||
|
2014
Q2 | $11M | Sell |
|
|||||
|
2014
Q1 | $14.4M | Buy |
|
|||||
|
2013
Q4 | $11.2M | Buy |
|
|||||
|
2013
Q3 | $6.43M | Buy |
|
|||||
|
2013
Q2 | $524K | Buy |
|